Is Salesforce or ServiceNow a Better Stock to Buy Right Now?

Salesforce reported fiscal Q1 revenue of $11.1 billion, up 13% year over year, while ServiceNow posted faster 22% revenue growth to $3.77 billion and 44% free cash flow margins. Salesforce trades at about 22x earnings versus roughly 67x for ServiceNow, but ServiceNow’s AI-related demand is accelerating, with $1 million-plus customers up more than 130% and AI target talk raised to $1.5 billion. The article favors ServiceNow on growth and business quality, despite its much richer valuation.

Analysis

The market is implicitly repricing enterprise software into two buckets: usage-based platforms that can monetize AI workload growth, and seat-based vendors that risk margin dilution if AI reduces human logins. That makes NOW structurally better positioned than CRM in the near term, but the real second-order winner is likely the cloud and infrastructure layer that captures the incremental compute, storage, and orchestration spend behind these agents. If AI adoption shifts value away from per-seat pricing, software with embedded workflow control should preserve pricing power longer than front-office CRM tools.

CRM’s setup is more interesting than the headline multiple suggests. A low P/E only matters if organic growth re-accelerates after the acquisition integration cycle; otherwise the stock can stay “cheap” for longer as investors wait for proof that Agentforce is an actual monetization engine rather than a product wedge. The key catalyst is not just revenue from AI, but evidence that AI attaches to existing workflows and expands wallet share without compressing margins — if that happens over the next 2-3 quarters, the rerating could be substantial.

NOW is the higher-quality compounder, but the market already knows that, so upside likely comes from continued estimate revisions rather than multiple expansion. The risk is a classic premium-growth setup: if enterprise AI budgets pause or implementation cycles stretch, the stock could de-rate quickly because expectations are anchored to sustained 20%+ growth. The best contrarian read is that CRM may be the better near-term mean reversion trade, while NOW remains the cleaner multi-year secular winner.

Key Decisions for Investors

• Long NOW / short CRM as a 3-6 month relative-value pair: thesis is that usage-based monetization and faster growth keep estimate revisions positive for NOW, while CRM remains valuation-supported but growth-capped; target 10-15% relative outperformance for NOW, stop if CRM shows 2 consecutive quarters of organic acceleration.
• Buy CRM on weakness for a 6-12 month reversal trade: the setup works only if post-Informatica integration doesn’t mask core demand; risk/reward improves below ~20x forward earnings if Agentforce traction converts into sustained ARR growth.
• Take profits or hedge NOW after sharp rallies: premium software with a 60s P/E can gap down hard on any guidance miss; use call spreads rather than outright longs to cap valuation risk over the next earnings cycle.
• Monitor INFA as a secondary beneficiary but lower-conviction trade: if CRM’s data layer integration works, INFA’s strategic value rises, but near-term upside is mostly acquisition optionality, not standalone fundamentals.